Radioimmunoconjugates

Known as: Radioimmunoconjugate, Radiolabeled Antibodies 
Monoclonal antibodies (MoAb) conjugated with radioisotopes, i.e., I-131, Y-90, T-99, or In-111. Using radioimmunoconjugates in radiotherapy or… (More)

Topic mentions per year

Topic mentions per year

1990-2017
024619902017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
177Lu-DOTA-HH1 (177Lu-HH1) is a novel anti-CD37 radioimmunoconjugate developed to treat non-Hodgkin lymphoma. Mice with… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2014
Review
2014
Radioimmunotherapy (RIT) has been developed for more than 30 years. Two products targeting the CD20 antigen are approved in the… (More)
Is this relevant?
2013
2013
The biodistribution of the anti-CD37 radioimmunoconjugate (177)Lu-tetraxetan-tetulomab ((177)Lu-DOTA-HH1) was evaluated… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2008
2008
Dextran and PEG-coated iron oxide nanoparticles (NP), when suitably modified to enable conjugation with molecular targeting… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
PURPOSE Tumors metastasizing to the CNS and leptomeninges (LM) are associated with significant mortality. We tested the toxicity… (More)
Is this relevant?
2006
2006
Sixteen patients with histologically proven malignant neopla sia were investigated by radioimmunodetection, using goat anti-a… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2003
2003
 
Is this relevant?
2000
2000
Effective targeted cancer therapy requires high selectivity and cytotoxicity. To this end we have prepared and tested a new alpha… (More)
Is this relevant?
1998
1998
We have synthesized two bifunctional derivatives of the macrocyclic chelating agent 1,4,7,10-tetraazacyclododecane-N,N',N",N… (More)
Is this relevant?
1994
1994
BACKGROUND Although chronic lymphocytic leukemia is usually indolent and responsive to treatment early in its course, later… (More)
Is this relevant?